Genmab — December 2019
-
Genmab's Commercial Engine Aspirations
Jan G. J. van de Winkel, Ph.D., cofounder and CEO of Genmab, discusses the company’s aspirations to eventually commercialize its own products....
(www.lifescienceleader.com)
-
Bibob og Mcjean - enig jeg hælder, ligesom jer og Solsen, til holdningen, spis lige brød til. Har bl.a. gennemtrevlet kommentarer på Twitter og andet og læser ikke andet end at man finder TAK interessant. At det skulle overgår Dara står ikke ligefrem at læse, men jeg er nu heller ikke forsker.
-
Enig , kunne heller ikke forstå den kindhest på 70 kr den anden dag
-
Ifm. Snakken om TAK-079 har CT 2 studier. Et ph 1B med 36 pat. Og et ph 1/2A med op til 100 Pat. Umiddelbart ikke store studier. https://www.clinicaltrials.gov/ct2/show/NCT03439280?term=TAK-079&cond=Multiple+Myeloma&draw=1&rank=2 https://www.clinicaltrials.gov/ct2/show/NCT03439280?term=TAK-079&cond=Multiple+Myeloma&draw=1&rank=2
-
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind